Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Breast cancer and Poland’s syndrome
Journal Information
Vol. 101. Issue 3.
Pages 228-231 (March 2023)
Vol. 101. Issue 3.
Pages 228-231 (March 2023)
Scientific Letter
Full text access
Breast cancer and Poland’s syndrome
Síndrome de Poland y cáncer de mama
Visits
28
Cristina de la Cruz Cuadrado
Corresponding author
cdelacruzcuadrado@gmail.com

Corresponding author.
, Borja Agustín Camacho Fernández-Pacheco, Ana Alicia Tejera Hernández, Víctor Vega Benítez, Juan Ramón Hernández Hernández
Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

Poland’s syndrome (PS) is a very rare congenital musculoskeletal disorder characterised by hypoplasia or absence of the pectoralis major muscle and may be associated with breast hypoplasia, ammastia, chest wall deformities and ipsilateral upper limb abnormalities. A higher incidence of certain malignant tumours, including infiltrating ductal carcinoma (IDC) of the breast, has been reported in these patients. We present 2 cases of PS associated with breast carcinoma operated on in our department, describing their characteristics and oncological evolution.

Case 1: A 39-year-old woman with right PS (breast hypoplasia, absence of pectoralis, shortening of the ipsilateral arm and malformations of the fingers), and with a history of a contralateral symmetry mammoplasty. She started with a 20 mm nodule in the upper outer quadrant of the right breast, with no pathological lymphadenopathies. Mammography showed a 2 cm spiculated nodule, BIRADS 5. The core needle biopsy indicated IDC. She underwent lumpectomy and sentinel node biopsy (SNB) with definitive anatomopathological results of grade III IDC, hormone receptor (HR) positive and Her2-positive enlargement, stage T1N0M0. After surgery, she evolved favourably and was discharged 24 h after surgery. She received 6 cycles of fluorouracil, epirubicin and cyclophosphamide (FEC) associated with trastuzumab for one year. In addition to radiotherapy (50 Gy + boost 10 Gy) and hormone therapy with tamoxifen for 5 years. There was no recurrence with a 10-year follow-up.

Case 2: A 48-year-old female patient with a history of right PS due to breast hypoplasia. She was assessed for pain and local discomfort in the right breast. Physical examination showed induration and retraction of the nipple, with no palpable nodules or lymph nodes. Mammography revealed small retroareolar punctate calcifications with no other alterations and a skin biopsy of the nipple was performed. The result was positive for stage T4bN0M0 IDC. She received neoadjuvant treatment with 4 cycles of doxorubicin and cyclophosphamide followed by 12 cycles of paclitaxel with subsequent skin-sparing mastectomy, SNB and immediate reconstruction with direct prosthesis. Pathological anatomy showed a 3 cm grade III IDC with free borders, HR positive, Ki-67 of 15% and negative Her2 magnification. The SNB was negative for metastasis. She had a satisfactory evolution and was discharged 48 h postoperatively. Subsequently, hormone therapy with exemestane was started, and treatment has been ongoing to date, with no evidence of tumour recurrence.

To date, 22 cases of PS associated with breast carcinoma have been described (Table 1). Of the cases described, 59% were in the left breast, with malignant degeneration of the hypoplastic breast in 86.3% of the cases, with the healthy breast being affected in only 9% and only one case with bilateral involvement. Histology was IDC in 95% of cases, with oestrogen and progesterone receptor positivity in 68% and 53%, respectively, and Her2 amplification in 54%. Mastectomy with or without reconstruction was performed in most cases (77%). Our cases showed a right predominance, with involvement of the hypoplastic breast by IDC and HR expression. Only one of them had Her2 enlargement (case 1).

Table 1.

Cases of Poland's syndrome and breast cancer reported in the literature.

Author  Age  Side  Breast involved  Histology  Hormonal receptors  Stage  Surgery  Hormonal treatment  CT  RT 
Fukushima et al., 1999  57  Right  Ipsilateral  IDC  O+P+Her2 N/R  IIAT1N1M0  Mastectomy + AE  −  −  − 
Fukushima et al., 1999  53  Left  Ipsilateral  IDC  O−P−Her2 N/R  IIAT2N0M0  Tumorectomy + AE  −  −  − 
Havlik et al., 1999  33  Right  Ipsilateral  IDC + ILC  O+P−Her2 N/R  IIAT2N0M0  Mastectomy + AE  −  −  − 
Katz et al., 2001  42  Left  Ipsilateral  IDC  O−P+Her2−  IAT1N0M0  Mastectomy + AE  −  − 
Okamo et al., 2002  59  Right  Contralateral  IDC  O+P+Her2 N/R  IIAT1N1bM0  Tumorectomy + AE  −  − 
Khandelwal et al., 2004  71  Right  Ipsilateral  IDC + ISDC  O+P−Her2−  IAT1N0M0  Mastectomy + AE  −  −  − 
Wong et al., 2004  51  Left  Ipsilateral  ISDC  ON/RP N/RHer2 N/R  0TisN0M0  Mastectomy  −  −  − 
Tamiolakis et al., 2004  53  Left  Ipsilateral  IDC  O−P+Her2−  IAT1N0M0  Mastectomy + AE  −  − 
Salhab et al., 2005  52  Left  Ipsilateral  IDC + ISDC  O N/RP N/RHer2 N/R  IAT1N0M0  Tumorectomy + SNB  −  −  − 
10  Wang et al., 2008  46  Right  Ipsilateral  IDC  O+P+Her2−  IIBT2N1M0  Mastectomy + AE  − 
11  Ji et al., 2008  58  Left  Ipsilateral  IDC  O N/RP N/RHer2 N/R  IIAT2N0M0  Mastectomy + AE  −  −  − 
12  Caussa et al., 2009  43  Left  Ipsilateral  IDC  O+P N/RHer2−  IIIAT3N1M0  Mastectomy + AE 
13  Yesilkaya et al., 2011  39  Left  Ipsilateral  IDC  O−P+Her2+  IIAT2N0M0  Mastectomy + AE  − 
14  Zhang et al., 2011  43  Left  Ipsilateral  IDC  O+P+Her2+  IIICT1N3M0  Mastectomy + AE  −  − 
15  DeFacio et al., 2017  62  Right  Contralateral  IDC  O−P−Her2+  IIAT2N0M0  Mastectomy bilateral + SNB  −  − 
16  DeFacio et al., 2018  69  Left  Ipsilateral  IDC  O+P−Her2-  IAT1bN0M0  Tumorectomy + SNB  −  − 
17  DeFacio et al., 2018  37  Right  Bilateral  R: ISDCL: IDC  O R+ L−P R− L−Her2 R+ L+  R: IAT1bN0M0I: IAT1cN0M0  Mastectomy + AE bilateral  −  −  − 
18  Huang et al., 2018  74  Left  Ipsilateral  IDC  O+P+Her2−  IIBT3N0M0  Mastectomy + AE  −  − 
19  Huang et al., 2018  60  Left  Ipsilateral  IDC  O−P−Her2+  IIIBT4N1M0  Mastectomy + AE  −  −  − 
20  Malatay Gonzalez et al., 2020  56  Left  Ipsilateral  IDC  O+P+Her2+  IVT3N0M1  Mastectomy + AE 
21  Case 1, 2007  39  Right  Ipsilateral  IDC  O+P+Her2+  IAT1cN0M0  Tumorectomy + SNB 
22  Case 2, 2018  48  Right  Ipsilateral  IDC  O+P+Her2−  IIIBT4bN0M0  Mastectomy + SNB  − 

AE: Axillary emptying; CT: Chemotherapy; IDC: Infiltrating ductal carcinoma; ILC: Infiltrating lobular carcinoma; ISDC: In situ ductal carcinoma; L: Left breast; N/R: Not reported; O: Oestrogen receptors; P: Progesterone receptors; R: Right breast; RT: Radiotherapy; SNB: Sentinel node biopsy.

PS is a congenital musculoskeletal disorder with an estimated incidence of 1:20,000 to 1:32,000 births,1 with a predilection for males.2 Breast involvement can range from mild hypoplasia to complete absence or ammastia.3 Seventy percent of cases affect the right side of the body.

Although the aetiology is unknown, the main defect is thought to be in the mesoderm from which the pectoral area and upper limb develop, due to decreased blood flow from the subclavian in this region during embryonic development.4 These vascular alterations have been demonstrated in some studies.5,6,8

The diagnosis of this disease is mainly clinical. In some cases, the clinical features are not so characteristic and may only present breast asymmetry or slight alterations of the chest wall, so this disease may be underdiagnosed. In this case, complementary imaging tests such as chest wall ultrasound, computed axial tomography or magnetic resonance imaging are recommended.5

Surgical treatment of breast cancer in these patients does not differ from that of the general population,9 although it is necessary to take extreme precautions to avoid thoracic lesions due to the possible absence of both pectoral muscles.8 Aesthetic correction of the hypoplastic breast requires individualised treatment and may require a contralateral symmetry mammoplasty.7 Greater caution should be exercised with the use of external radiotherapy in these patients, as it carries a higher risk of pulmonary and cardiac lesions and complications due to the absence of pectoral muscle to protect the intrathoracic organs.

Future studies are needed to establish a definitive relationship between the two pathologies, although this could be complicated due to the low incidence of this disease and the greater involvement of males.

To date, 22 cases of SP associated with breast carcinoma have been reported. Although there is no definitive association between the two, there may be an increased risk of cancer in these patients. We therefore recommend closer follow-up and a high level of suspicion when nodules or other breast alterations appear.

Conflict of interests

The authors have no conflict of interests to declare.

References
[1]
N.F. Freire-Maia, E.A. Chautard, J.M. Opitz, A. Freire-Maia, A. Quelce-Salgado.
The Poland syndrome: Clinical and genealogical data, dermatoglyphic analysis, and incidence.
Hum. Hered., 23 (1973), pp. 97-104
[2]
A.A. Fokin, F. Robicsek.
Poland’s syndrome revisited.
Ann Thorac Surg, 74 (2002), pp. 2218-2225
[3]
KI Bland, EM. Copeland.
The Breast: Comprehensive Management of Benign and Malignant Diseases.
Ann Surg, 215 (1992), pp. 192
[4]
JN Bavinck, DD. Weaver.
Subclavian artery supply disruption sequence: hypothesis of a vascular etiology for Poland, Klippel-Feil, and Mobius anomalies.
Am J Med Genet., 23 (1986), pp. 903-918
[5]
H.J. Mentzel, J. Seidel, D. Sauner, et al.
Radiological aspects of the Poland syndrome and implications for treatment: a case study and review.
Eur J Pediatr., 161 (2002), pp. 455-459
[6]
S.C. Katz, A. Hazen, S.R. Colen, Roses DF.
Poland’s syndrome and carcinoma of the breast: A case report.
[7]
A. Mojallal, S. La Marca, C. Shipkov, R. Sinna, F. Braye.
Poland syndrome and breast tumor: a case report and review of the literature.
Aesthet Surg J., 32 (2012), pp. 77-83
[8]
M.V. DeFazio, O.A. Dervishaj, L.M. Bozzuto, T.A. Pittman, M.J. Olding, E.A. Tousimis, et al.
Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland’s Anomaly: Report of 2 Rare Cases and Review of the Literature.
Clin Breast Cancer., 18 (2018), pp. 285-290
[9]
C Malatay Gonzalez, et al.
Cáncer de mama asociado a síndrome de Poland.
Revista de Senología y Patología Mamaria, (2021),
Copyright © 2022. AEC
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.cireng.2019.03.007
No mostrar más